Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Hypertension II: Pathophysiology
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Psychoneuroimmunology: Cardiovascular Disease
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 12, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Zhongjian Cheng1, Xiaofeng Yang, Hong Wang
1Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA.
Hyperhomocysteinemia (HHcy) significantly increases cardiovascular disease risk by causing endothelial dysfunction (ED). This review details six key mechanisms, including nitric oxide inhibition and oxidative stress, through which HHcy induces ED.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: